Atorvastatin Post-Conditioning Attenuates Myocardial Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress–Related Apoptosis
- 1 October 2014
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 42 (4), 365-371
- https://doi.org/10.1097/shk.0000000000000224
Abstract
The present study examined whether atorvastatin, when used for pharmacological postconditioning, attenuated myocardial ischemia-reperfusion (I/R) injury in a manner similar to ischemic postconditioning (I-PostC), that is, by inhibition of endoplasmic reticulum (ER) stress-related apoptosis. In the present study, markers for myocardial injury, infarct area, and hemodynamics, and indicators of ER stress and apoptosis were compared in ischemic and atorvastatin-induced postconditioning as a means of evaluating the protective effect of atorvastatin postconditioning in I/R injury and whether, as in I-PostC, inhibition of ER stress is involved. Both ischemic and atorvastatin-mediated postconditioning significantly decreased indications of cardiac damage and reduced serum concentrations of markers for myocardial injury, reduced the infarct area seen at the end of reperfusion, and improved left ventricular systolic function. We found that high-dose atorvastatin- and I-PostC significantly downregulated expression of glucose-regulating protein 78 and calreticulin (CRT; ER stress markers), expression of C/EBP homologous protein (CHOP), and caspase 12 (markers for ER stress-related apoptosis), and Bax (downstream molecule of CHOP), in the myocardial area at risk. Atorvastatin and I-PostC have similar cardioprotective effects in I/R injury and inhibit the ER stress-related apoptotic pathway.Keywords
This publication has 29 references indexed in Scilit:
- Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trialsTherapeutic Advances in Cardiovascular Disease, 2012
- New Method of Intracoronary Adenosine Injection to Prevent Microvascular Reperfusion Injury in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology, 2011
- Postconditioning in Acute Myocardial Infarction PatientsAntioxidants and Redox Signaling, 2011
- Myocardial Protection with Isoflurane During Off-Pump Coronary Artery Bypass Grafting: A Randomized TrialJournal of Cardiothoracic and Vascular Anesthesia, 2011
- Roles of Cyclooxygenase 2 in Sevoflurane- and Olprinone-Induced Early Phase of Preconditioning and Postconditioning Against Myocardial Infarction in Rat HeartsJournal of Cardiovascular Pharmacology and Therapeutics, 2010
- Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseVascular and Endovascular Surgery, 2010
- Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibitionBasic Research in Cardiology, 2009
- Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt PathwayCirculation Research, 2004
- Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathwayJournal of the American College of Cardiology, 2003